|
Volumn 98, Issue 5, 2001, Pages 2652-2657
|
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (ACETYLOXY)BENZOIC ACID 3 (NITROOXYMETHYL)PHENYL ESTER;
CASPASE 3;
CASPASE 8;
CASPASE 9;
CONCANAVALIN A;
FAS ANTIGEN;
GAMMA INTERFERON;
INTERLEUKIN 18;
INTERLEUKIN 1BETA;
NCX 1000;
UNCLASSIFIED DRUG;
URSODEOXYCHOLIC ACID;
URSODEOXYCHOLIC ACID DERIVATIVE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIGEN EXPRESSION;
APOPTOSIS;
ARTICLE;
AUTOIMMUNE HEPATITIS;
CELL PROTECTION;
CYTOKINE RELEASE;
CYTOTOXICITY;
DRUG ACTIVITY;
ENZYME INHIBITION;
HELPER CELL;
HUMAN;
HUMAN CELL;
LIVER INJURY;
MALE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
ANIMALS;
BASE SEQUENCE;
CASPASES;
CYSTEINE PROTEINASE INHIBITORS;
CYTOKINES;
DNA PRIMERS;
DOWN-REGULATION;
FAS LIGAND PROTEIN;
HEPATITIS, AUTOIMMUNE;
HUMANS;
LIVER;
MALE;
MEMBRANE GLYCOPROTEINS;
MICE;
MICE, INBRED BALB C;
NITRATES;
RNA, MESSENGER;
SALICYLIC ACIDS;
TUMOR CELLS, CULTURED;
URSODEOXYCHOLIC ACID;
ANIMALIA;
MURINAE;
|
EID: 0035956909
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.041603898 Document Type: Article |
Times cited : (95)
|
References (41)
|